Private Harbour Investment Management & Counsel Llc decreased Abbvie Inc (ABBV) stake by 54.22% reported in 2017Q3 SEC filing. Private Harbour Investment Management & Counsel Llc sold 17,138 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Private Harbour Investment Management & Counsel Llc holds 14,471 shares with $1.29 million value, down from 31,609 last quarter. Abbvie Inc now has $189.34 billion valuation. The stock increased 3.22% or $3.7 during the last trading session, reaching $118.6. About 8.83M shares traded or 49.76% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 17, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.
Koss Corporation (NASDAQ:KOSS) had a decrease of 52.38% in short interest. KOSS’s SI was 4,000 shares in February as released by FINRA. Its down 52.38% from 8,400 shares previously. With 42,000 avg volume, 0 days are for Koss Corporation (NASDAQ:KOSS)’s short sellers to cover KOSS’s short positions. The SI to Koss Corporation’s float is 0.24%. The stock decreased 3.05% or $0.06 during the last trading session, reaching $1.91. About 24,221 shares traded. Koss Corporation (NASDAQ:KOSS) has declined 15.95% since February 17, 2017 and is downtrending. It has underperformed by 32.65% the S&P500.
Koss Corporation, together with its subsidiaries, designs, makes, and sells stereo headphones and related accessories in the United States, PeopleÂ’s Republic of China, Czech Republic, Sweden, Malaysia, Canada, Russia, and internationally. The company has market cap of $14.10 million. It offers high-fidelity headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise canceling headphones. It currently has negative earnings. The firm sells its products through national retailers, distributors, audio specialty stores, the Internet, direct mail catalogs, regional department store chains, discount department stores, grocery stores, electronics retailers, military exchanges, and prisons under the Koss name, as well as private label.
Investors sentiment decreased to 0.5 in 2017 Q3. Its down 0.50, from 1 in 2017Q2. It fall, as 2 investors sold Koss Corporation shares while 4 reduced holdings. 1 funds opened positions while 2 raised stakes. 653,922 shares or 23.36% more from 530,088 shares in 2017Q2 were reported. Minerva Limited Liability Company, Pennsylvania-based fund reported 241,210 shares. Moreover, Wells Fargo Company Mn has 0% invested in Koss Corporation (NASDAQ:KOSS). Retail Bank Of Ny Mellon has invested 0% in Koss Corporation (NASDAQ:KOSS). California Pub Employees Retirement Systems has 20,416 shares for 0% of their portfolio. Moreover, Vanguard Grp has 0% invested in Koss Corporation (NASDAQ:KOSS) for 16,064 shares. Bank Of America Corp De accumulated 19,585 shares or 0% of the stock. Northern Tru invested 0% of its portfolio in Koss Corporation (NASDAQ:KOSS). Moreover, Us Bancorporation De has 0% invested in Koss Corporation (NASDAQ:KOSS). Renaissance Limited Com invested in 0% or 15,800 shares. Dimensional Fund Advsr L P stated it has 185,505 shares. Blackrock has invested 0% in Koss Corporation (NASDAQ:KOSS). Cibc Natl Bank Usa owns 79,661 shares. Morgan Stanley reported 0% stake.
Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Abbvie Inc had 78 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies maintained AbbVie Inc. (NYSE:ABBV) rating on Thursday, January 4. Jefferies has “Buy” rating and $120.0 target. The firm has “Market Perform” rating given on Monday, June 6 by Cowen & Co. TheStreet upgraded the stock to “Buy” rating in Tuesday, August 11 report. Cowen & Co upgraded the shares of ABBV in report on Wednesday, October 11 to “Outperform” rating. Atlantic Securities initiated AbbVie Inc. (NYSE:ABBV) on Friday, December 18 with “Neutral” rating. SunTrust maintained the stock with “Buy” rating in Monday, October 16 report. Cowen & Co maintained it with “Hold” rating and $7000 target in Friday, July 28 report. Morgan Stanley downgraded the shares of ABBV in report on Wednesday, June 8 to “Equal-Weight” rating. Deutsche Bank maintained AbbVie Inc. (NYSE:ABBV) rating on Monday, July 17. Deutsche Bank has “Hold” rating and $6 target. The firm has “Buy” rating by Piper Jaffray given on Thursday, September 28.
Since September 11, 2017, it had 0 insider purchases, and 5 selling transactions for $25.59 million activity. On Monday, September 11 SALEKI-GERHARDT AZITA sold $705,655 worth of AbbVie Inc. (NYSE:ABBV) or 8,300 shares. On Monday, October 30 Gosebruch Henry O sold $1.66 million worth of AbbVie Inc. (NYSE:ABBV) or 18,300 shares. On Monday, December 18 RICHMOND TIMOTHY J. sold $8.57 million worth of AbbVie Inc. (NYSE:ABBV) or 87,040 shares. 145,510 shares were sold by Schumacher Laura J, worth $14.07 million. $589,512 worth of AbbVie Inc. (NYSE:ABBV) was sold by Michael Robert A. on Thursday, September 28.